In Episode 2 of Unlocking Antiarrhythmics From ABCs to Action, #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Jose L. Merino, MD, PhD to explore what it means to truly personalize antiarrhythmic drug (AAD) therapy across diverse patient populations. Together, they discuss real-world strategies for tailoring treatment based on age, comorbidities, arrhythmia type, and individual risk factors — highlighting how precision medicine is reshaping rhythm management. From dosing considerations to emerging research and clinical challenges, viewers will gain actionable insight to help optimize AAD use in varied care settings and deliver more confident, patient-centered treatment.
Stay tuned for Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home
Additional Resources
https://academic.oup.com/europace/article/27/8/euaf076/8100306?login=true
https://www.jacc.org/doi/10.1016/j.jacep.2024.11.020
Listen on:
Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
Resource Type
- HRStv Podcast
Related Resources
HRStv Podcast
Episode 133: Understanding Postural Orthostatic Tachycardia Syndrome
March 4, 2026
HRStv Podcast
Episode 132: Early Outcomes of the VERITAS Study and Amulet 360
February 27, 2026
HRStv Podcast
Episode 131: Unlocking Antiarrhythmics From ABCs to Action — Next-Gen Rhythm Monitoring at Home
February 13, 2026